Sernova (TSE:SVA) Trading Down 7.1% – Should You Sell?

Sernova Corp. (TSE:SVA) shares fell 7.1% during mid-day trading on Friday . The company traded as low as C$0.13 and last traded at C$0.13. 209,050 shares changed hands during mid-day trading, an increase of 75% from the average daily volume of 119,224 shares. The stock had previously closed at C$0.14.

Sernova Stock Performance

The company has a quick ratio of 18.11, a current ratio of 0.14 and a debt-to-equity ratio of -25.45. The business’s fifty day simple moving average is C$0.16 and its two-hundred day simple moving average is C$0.15. The company has a market cap of C$52.87 million, a price-to-earnings ratio of -3.50 and a beta of -0.34.

Sernova (TSE:SVA) last posted its earnings results on Thursday, June 11th. The company reported C$0.01 earnings per share for the quarter. On average, equities analysts predict that Sernova Corp. will post -0.08 EPS for the current year.

About Sernova

Sernova Biotherapeutics is a clinical-stage company developing regenerative medicine therapeutics combining its Cell Pouch with human donor cells or stem-cell derived islet-like clusters in collaboration with Evotec to create bio-hybrid organs to treat T1D. A bio-hybrid organ is comprised of non-biomaterials, such as the Cell Pouch, integrated with living tissues to restore or enhance the function of a compromised organ. This innovative approach aims to deliver a potentially revolutionary treatment for patients with chronic diseases, initially focusing on T1D and thyroid disorders.